January 29, 2018 Sinclair Pharma is pleased to announce an exciting study on Silhouette InstaLift™, a minimally invasive procedure to lift the skin of the mid-face, published in The Aesthetic Surgery Journal (ASJ) assessing the safety, efficacy and satisfaction of absorbable suture suspension. The 100-patient study that appeared in the December 2017 ASJ demonstrated high patient satisfaction with Silhouette InstaLift for lifting of the mid-face while improving a number of age related changes. Key findings include that 96 percent of survey respondents found Silhouette InstaLift to be a tolerable treatment while 83 percent of respondents found that the treatment improves age related changes. Sinclair Pharma plc published this content on 29 January 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 29 January 2018 17:34:04 UTC.
Sinclair Pharma's Silhouette InstaLift received high scores in an Aesthetic Surgery Journal (ASJ) study assessing its efficacy and safety. The ASJ is a peer-reviewed journal that publishes clinical research on cosmetic surgery for the treatment of aesthetic conditions such as breast augmentation or liposuction. The survey found 96% of respondents to the ASJ's 100-patient survey said it was a tolerable treatment and 83% said InstaLift improves age-related changes.